David Geffen School of Medicine at UCLA

Site:	David Geffen School of Medicine at UCLA
Address:	10833 Le Conte Ave
City:	Los Angeles
State:	CA
Zip:	90095
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug	NCT#
1	Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients.	Ongoing, but not recruiting	Closed	AUY922	NCT00526045
1	Continuous Dosing of Regorafenib in Patients With Advanced Malignancies	Ongoing, but not recruiting	Closed	Regorafenib (BAY 73-4506)	NCT01117623